IL6 and hepatocellular carcinoma: Elevated levels of IL-6 have been associated with HCC in human patients46, and in the case of Castleman's disease, hypersecretion of IL-6 leads to the formation of HCC tumours, as well as systemic inflammatory symptoms47.